GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - FRA:GXI - DE000A0LD6E6 - Common Stock
27.6 EUR
-0.14 (-0.5%)
GXI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of GXI have multiple concerns. GXI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
GXI had positive earnings in the past year.
GXI had a positive operating cash flow in the past year.
In the past 5 years GXI has always been profitable.
Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
GXI has a worse Return On Assets (0.50%) than 85.00% of its industry peers.
The Return On Equity of GXI (1.67%) is worse than 85.00% of its industry peers.
GXI has a worse Return On Invested Capital (2.79%) than 85.00% of its industry peers.
GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is in line with the industry average of 7.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a worse Profit Margin (1.04%) than 85.00% of its industry peers.
GXI's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 5.99%, GXI is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
GXI's Operating Margin has improved in the last couple of years.
GXI has a Gross Margin of 26.89%. This is in the lower half of the industry: GXI underperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GXI has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GXI has been increased compared to 5 years ago.
GXI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.96, we must say that GXI is in the distress zone and has some risk of bankruptcy.
GXI's Altman-Z score of 0.96 is on the low side compared to the rest of the industry. GXI is outperformed by 80.00% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that GXI has dependencies on debt financing.
GXI has a worse Debt to Equity ratio (1.22) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.96 |
ROIC/WACC0.36
WACC7.72%
2.3 Liquidity
A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
The Current ratio of GXI (0.98) is worse than 75.00% of its industry peers.
A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.52, GXI is doing worse than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased strongly by -19.08% in the last year.
Measured over the past years, GXI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
Looking at the last year, GXI shows a quite strong growth in Revenue. The Revenue has grown by 11.83% in the last year.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
The Earnings Per Share is expected to grow by 8.98% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.51% on average over the next years. This is quite good.
EPS Next Y-18.32%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
EPS Next 5Y8.98%
Revenue Next Year17.05%
Revenue Next 2Y11.28%
Revenue Next 3Y9.65%
Revenue Next 5Y8.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.48, which indicates a rather cheap valuation of GXI.
Based on the Price/Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.11. GXI is valued rather cheaply when compared to this.
GXI is valuated cheaply with a Price/Forward Earnings ratio of 5.75.
100.00% of the companies in the same industry are more expensive than GXI, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.55. GXI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.48 | ||
| Fwd PE | 5.75 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GXI indicates a rather cheap valuation: GXI is cheaper than 95.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.52 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.28%
EPS Next 3Y7.45%
5. Dividend
5.1 Amount
With a yearly dividend of 0.14%, GXI is not a good candidate for dividend investing.
The stock price of GXI dropped by -34.29% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
GXI's Dividend Yield is slightly below the industry average, which is at 0.72.
Compared to an average S&P500 Dividend Yield of 2.37, GXI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.14% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP10.12%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
FRA:GXI (10/31/2025, 7:00:00 PM)
27.6
-0.14 (-0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.48%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap953.30M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts72.17
Price Target40.1 (45.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.14% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-39.27%
PT rev (3m)-40.2%
EPS NQ rev (1m)-30.91%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.45%
Revenue NQ rev (1m)-9.83%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.48 | ||
| Fwd PE | 5.75 | ||
| P/S | 0.42 | ||
| P/FCF | N/A | ||
| P/OCF | 3.76 | ||
| P/B | 0.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.52 |
EPS(TTM)3.69
EY13.37%
EPS(NY)4.8
Fwd EY17.39%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY26.6%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.96 |
F-Score4
WACC7.72%
ROIC/WACC0.36
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-18.32%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
EPS Next 5Y8.98%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year17.05%
Revenue Next 2Y11.28%
Revenue Next 3Y9.65%
Revenue Next 5Y8.51%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year113.62%
EBIT Next 3Y38.46%
EBIT Next 5Y24.57%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -18.32% in the next year.